Inventor

BESPALOV ANTON

DE8 patents

⚠️ This page may combine multiple inventors who share the name “BESPALOV ANTON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBOTT GMBH & CO KG

3 patents

US8343959B2Jan 1, 2013

N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

ABBOTT GMBH & CO KG5 citations72

US8362010B2Jan 29, 2013

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

ABBOTT GMBH & CO KG2 citations61

US7790727B2Sep 7, 2010

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

ABBOTT GMBH & CO KG4 citations60

HAUPT ANDREAS

2 patents

US8076326B2Dec 13, 2011

N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

HAUPT ANDREAS23 citations90

US8183237B2May 22, 2012

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

HAUPT ANDREAS4 citations60

EXCIVA UG HAFTUNGSBESCHRAENKT

1 patent

US11103499B2Aug 31, 2021

Compositions and methods thereof

EXCIVA UG HAFTUNGSBESCHRAENKT4 citations62

BRAJE WILFRIED

1 patent

US8492540B2Jul 23, 2013

1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

BRAJE WILFRIED0 citations51

VEPACHEDU SREENIVASARAO

1 patent

US11478467B2Oct 25, 2022

Targeted drug rescue with novel compositions, combinations, and methods thereof

VEPACHEDU SREENIVASARAO0 citations39